These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

694 related articles for article (PubMed ID: 33847835)

  • 1. SKI activates the Hippo pathway via LIMD1 to inhibit cardiac fibroblast activation.
    Landry NM; Rattan SG; Filomeno KL; Meier TW; Meier SC; Foran SJ; Meier CF; Koleini N; Fandrich RR; Kardami E; Duhamel TA; Dixon IMC
    Basic Res Cardiol; 2021 Apr; 116(1):25. PubMed ID: 33847835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Ski-Zeb2-Meox2 pathway provides a novel mechanism for regulation of the cardiac myofibroblast phenotype.
    Cunnington RH; Northcott JM; Ghavami S; Filomeno KL; Jahan F; Kavosh MS; Davies JJ; Wigle JT; Dixon IM
    J Cell Sci; 2014 Jan; 127(Pt 1):40-9. PubMed ID: 24155330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ski drives an acute increase in MMP-9 gene expression and release in primary cardiac myofibroblasts.
    Landry N; Kavosh MS; Filomeno KL; Rattan SG; Czubryt MP; Dixon IMC
    Physiol Rep; 2018 Nov; 6(22):e13897. PubMed ID: 30488595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis.
    Liu F; Lagares D; Choi KM; Stopfer L; Marinković A; Vrbanac V; Probst CK; Hiemer SE; Sisson TH; Horowitz JC; Rosas IO; Fredenburgh LE; Feghali-Bostwick C; Varelas X; Tager AM; Tschumperlin DJ
    Am J Physiol Lung Cell Mol Physiol; 2015 Feb; 308(4):L344-57. PubMed ID: 25502501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-34a/miR-93 target c-Ski to modulate the proliferaton of rat cardiac fibroblasts and extracellular matrix deposition in vivo and in vitro.
    Zhang C; Zhang Y; Zhu H; Hu J; Xie Z
    Cell Signal; 2018 Jun; 46():145-153. PubMed ID: 29551367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ski regulates Hippo and TAZ signaling to suppress breast cancer progression.
    Rashidian J; Le Scolan E; Ji X; Zhu Q; Mulvihill MM; Nomura D; Luo K
    Sci Signal; 2015 Feb; 8(363):ra14. PubMed ID: 25670202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast mechanosensing, SKI and Hippo signaling and the cardiac fibroblast phenotype: Looking beyond TGF-β.
    Landry NM; Dixon IMC
    Cell Signal; 2020 Dec; 76():109802. PubMed ID: 33017619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of Yap/Taz in cardiac fibroblasts attenuates adverse remodelling and improves cardiac function.
    Mia MM; Cibi DM; Ghani SABA; Singh A; Tee N; Sivakumar V; Bogireddi H; Cook SA; Mao J; Singh MK
    Cardiovasc Res; 2022 Jun; 118(7):1785-1804. PubMed ID: 34132780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiscale Analysis of Extracellular Matrix Remodeling in the Failing Heart.
    Perestrelo AR; Silva AC; Oliver-De La Cruz J; Martino F; Horváth V; Caluori G; Polanský O; Vinarský V; Azzato G; de Marco G; Žampachová V; Skládal P; Pagliari S; Rainer A; Pinto-do-Ó P; Caravella A; Koci K; Nascimento DS; Forte G
    Circ Res; 2021 Jan; 128(1):24-38. PubMed ID: 33106094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic Chromatin Targeting of BRD4 Stimulates Cardiac Fibroblast Activation.
    Stratton MS; Bagchi RA; Felisbino MB; Hirsch RA; Smith HE; Riching AS; Enyart BY; Koch KA; Cavasin MA; Alexanian M; Song K; Qi J; Lemieux ME; Srivastava D; Lam MPY; Haldar SM; Lin CY; McKinsey TA
    Circ Res; 2019 Sep; 125(7):662-677. PubMed ID: 31409188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notch3 Ameliorates Cardiac Fibrosis After Myocardial Infarction by Inhibiting the TGF-β1/Smad3 Pathway.
    Zhang M; Pan X; Zou Q; Xia Y; Chen J; Hao Q; Wang H; Sun D
    Cardiovasc Toxicol; 2016 Oct; 16(4):316-24. PubMed ID: 26487518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylcytidine modification of Amotl1 by N-acetyltransferase 10 contributes to cardiac fibrotic expansion in mice after myocardial infarction.
    Wang XX; Zhao YM; Zhang QY; Zhao JX; Yin DH; Zhang ZZ; Jin XY; Li SN; Ji HY; Chen HY; Guo XF; Yu Y; Ma WY; Yan H; Li H; Ou-Yang QM; Pan ZW; Liang HH; Wang N; Chen W; Cai BZ; Liu Y
    Acta Pharmacol Sin; 2024 Jul; 45(7):1425-1437. PubMed ID: 38839936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gingival proteomics reveals the role of TGF beta and YAP/TAZ signaling in Raine syndrome fibrosis.
    Costa CRR; Chalgoumi R; Baker A; Guillou C; Yamaguti PM; Simancas Escorcia V; Abbad L; Amorin BR; de Lima CL; Cannaya V; Benassarou M; Berdal A; Chatziantoniou C; Cases O; Cosette P; Kozyraki R; Acevedo AC
    Sci Rep; 2024 Apr; 14(1):9497. PubMed ID: 38664418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matricellular protein CCN1 promotes collagen alignment and scar integrity after myocardial infarction.
    Fischer AG; Elliott EM; Brittian KR; Garrett L; Sadri G; Aebersold J; Singhal RA; Nong Y; Leask A; Jones SP; Moore Iv JB
    Matrix Biol; 2024 Nov; 133():14-32. PubMed ID: 39098433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of yes-associated protein/YAP and transcriptional coactivator with PDZ-binding motif/TAZ activates intestinal fibroblasts to promote intestinal obstruction in Crohn's disease.
    Ou W; Xu W; Liu F; Guo Y; Huang Z; Feng T; Liu CY; Du P
    EBioMedicine; 2021 Jul; 69():103452. PubMed ID: 34186485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifibrotic properties of c-Ski and its regulation of cardiac myofibroblast phenotype and contractility.
    Cunnington RH; Wang B; Ghavami S; Bathe KL; Rattan SG; Dixon IM
    Am J Physiol Cell Physiol; 2011 Jan; 300(1):C176-86. PubMed ID: 20943957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GPCR-mediated YAP/TAZ inactivation in fibroblasts via EPAC1/2, RAP2C, and MAP4K7.
    Choi KM; Haak AJ; Diaz Espinosa AM; Cummins KA; Link PA; Aravamudhan A; Wood DK; Tschumperlin DJ
    J Cell Physiol; 2021 Nov; 236(11):7759-7774. PubMed ID: 34046891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTRP3 attenuates post-infarct cardiac fibrosis by targeting Smad3 activation and inhibiting myofibroblast differentiation.
    Wu D; Lei H; Wang JY; Zhang CL; Feng H; Fu FY; Li L; Wu LL
    J Mol Med (Berl); 2015 Dec; 93(12):1311-25. PubMed ID: 26138247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic expression of Ski induces apoptosis and represses autophagy in cardiac myofibroblasts.
    Zeglinski MR; Davies JJ; Ghavami S; Rattan SG; Halayko AJ; Dixon IM
    Biochim Biophys Acta; 2016 Jun; 1863(6 Pt A):1261-8. PubMed ID: 27039037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble transforming growth factor-beta1 receptor II might inhibit transforming growth factor-beta-induced myofibroblast differentiation and improve ischemic cardiac function after myocardial infarction in rats.
    Lian R; Chen Y; Xu Z; Zhang X
    Coron Artery Dis; 2010 Sep; 21(6):369-77. PubMed ID: 20613497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.